Zebrafish Cancer Predisposition Models

Abstract

Cancer predisposition syndromes are rare, typically monogenic disorders that result from germline mutations that increase the likelihood of developing cancer. Although these disorders are individually rare, resulting cancers collectively represent 5–10% of all malignancies. In addition to a greater incidence of cancer, affected individuals have an earlier tumor onset and are frequently subjected to long-term multi-modal cancer screening protocols for earlier detection and initiation of treatment. In vivo models are needed to better understand tumor-driving mechanisms, tailor patient screening approaches and develop targeted therapies to improve patient care and disease prognosis. The zebrafish (Danio rerio) has emerged as a robust model for cancer research due to its high fecundity, time- and cost-efficient genetic manipulation and real-time high-resolution imaging. Tumors developing in zebrafish cancer models are histologically and molecularly similar to their human counterparts, confirming the validity of these models. The zebrafish platform supports both large-scale random mutagenesis screens to identify potential candidate/modifier genes and recently optimized genome editing strategies. These techniques have greatly increased our ability to investigate the impact of certain mutations and how these lesions impact tumorigenesis and disease phenotype. These unique characteristics position the zebrafish as a powerful in vivo tool to model cancer predisposition syndromes and as such, several have already been created, including those recapitulating Li-Fraumeni syndrome, familial adenomatous polyposis, RASopathies, inherited bone marrow failure syndromes, and several other pathogenic mutations in cancer predisposition genes. In addition, the zebrafish platform supports medium- to high-throughput preclinical drug screening to identify compounds that may represent novel treatment paradigms or even prevent cancer evolution. This review will highlight and synthesize the findings from zebrafish cancer predisposition models created to date. We will discuss emerging trends in how these zebrafish cancer models can improve our understanding of the genetic mechanisms driving cancer predisposition and their potential to discover therapeutic and/or preventative compounds that change the natural history of disease for these vulnerable children, youth and adults.

MicroRNA-21 Plays Multiple Oncometabolic Roles in Colitis-Associated Carcinoma and Colorectal Cancer via the PI3K/AKT, STAT3, and PDCD4/TNF-α Signaling Pathways in Zebrafish

“…Compared to human cell lines or genetically engineered mouse models, zebrafish provide unique insights into the progression and pathogenesis of cancer. The features of cancer development in zebrafish are similar to those observed in humans [ 31 , 32 ]. Hence, in recent years, zebrafish are being increasingly used as model organisms for cancer research [ 33 , 34 , 35 ].…”

Effectiveness of zebrafish models in understanding human diseases—A review of models

“…This doesn't allow for a proper investigation into the protein interactions or the genetic basis of the disease. [ 117 ] Limitations in Blood Disease Modelling Studying lymphocyte subtypes and the biology of leukocytes is difficult due to the scarcity of well-characterized monoclonal antibodies acting on the leukocyte surface molecule. [ 118 ] The difference in the morphology of some blood cells like erythrocytes and thrombocytes which are nucleated in zebrafish models might cause a hindrance in drawing parallels with humans and translating research.…”

Zebrafish as a Model to Study Retinoic Acid Signaling in Development and Disease

“…Within the realm of cancer biology, the zebrafish model has emerged as an efficient in vivo model, much for the same reasons why it is so popular in development. Thankfully, due to high amounts of conservation between the human and zebrafish genome, many oncologic markers are subsequently retained, making the fish useful for studying many aspects of cancer biology ( Figure 4 ) [ 158 , 236 , 237 ]. The zebrafish immune system allows for tissue xenografts from mammalian donors, allowing for not only large-scale drug and genetic screens to take place, but also holding promise for a future in precision medicine [ 238 , 239 , 240 , 241 ].…”